GO
Loading...

Celgene Corp

More

  • Final Glance: Biotechnology companies Thursday, 26 Feb 2015 | 6:02 PM ET

    Amgen Inc. rose$. 89 or. 6 percent, to $158.97. Biogen Idec rose $1.16 or. 3 percent, to $410.10. Celgene Corp. rose$. 25 or. 2 percent, to $123.35.

  • Midday Glance: Biotechnology companies Thursday, 26 Feb 2015 | 1:19 PM ET

    Amgen Inc. rose$. 82 or. 5 percent, to $158.90. Biogen Idec rose$. 94 or. 2 percent, to $409.88. Celgene Corp. rose$. 03 or percent, to $123.13.

  • Early Glance: Biotechnology companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Amgen Inc. fell $1.58 or 1.0 percent, to $156.50. Biogen Idec fell $2.44 or. 6 percent, to $406.50. Celgene Corp. fell $1.02 or. 8 percent, to $122.08.

  • Midday Glance: Biotechnology companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Amgen Inc. rose$. 76 or. 5 percent, to $158.13. Biogen Idec rose $5.19 or 1.3 percent, to $410.08. Celgene Corp. rose$. 26 or. 2 percent, to $123.44.

  • Early Glance: Biotechnology companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Amgen Inc. fell$. 12 or. 1 percent, to $157.25. Biogen Idec fell$. 90 or. 2 percent, to $403.99. Celgene Corp. fell$. 77 or. 6 percent, to $122.41.

  • Final Glance: Biotechnology companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Amgen Inc. fell $1.05 or. 7 percent, to $157.37. Biogen Idec fell $3.69 or. 9 percent, to $404.89. Celgene Corp. fell$. 64 or. 5 percent, to $123.18.

  • Midday Glance: Biotechnology companies Tuesday, 24 Feb 2015 | 1:17 PM ET

    Amgen Inc. fell $1.39 or. 9 percent, to $157.03. Biogen Idec fell $4.78 or 1.2 percent, to $403.80. Celgene Corp. fell $1.52 or 1.2 percent, to $122.30.

  • Early Glance: Biotechnology companies Tuesday, 24 Feb 2015 | 11:24 AM ET

    Amgen Inc. fell$. 48 or. 3 percent, to $157.94. Biogen Idec fell $1.79 or. 4 percent, to $406.80. Celgene Corp. fell $1.16 or. 9 percent, to $122.66.

  • Final Glance: Biotechnology companies Monday, 23 Feb 2015 | 6:04 PM ET

    Amgen Inc. rose$. 76 or. 5 percent, to $158.42. Biogen Idec rose$. 53 or. 1 percent, to $408.58. Celgene Corp. rose$. 39 or. 3 percent, to $123.82.

  • Feb 23- The U.S. Food and Drug Administration on Monday approved Novartis AG's drug to treat patients who have relapsed after earlier therapies for multiple myeloma, an aggressive blood cancer, even though an advisory panel in November recommended against approval. Farydak was approved for use in combination with Takeda Pharmaceutical Co Ltd's Velcade and...

  • Midday Glance: Biotechnology companies Monday, 23 Feb 2015 | 1:20 PM ET

    Amgen Inc. rose$. 94 or. 6 percent, to $158.60. Biogen Idec rose$. 07 or percent, to $408.12. Celgene Corp. rose $1.13 or. 9 percent, to $124.56.

  • Early Glance: Biotechnology companies Monday, 23 Feb 2015 | 10:40 AM ET

    Amgen Inc. rose$. 91 or. 6 percent, to $158.57. Biogen Idec rose$. 73 or. 2 percent, to $408.78. Celgene Corp. rose $1.37 or 1.1 percent, to $124.80.

  • Final Glance: Biotechnology companies Friday, 20 Feb 2015 | 6:00 PM ET

    Amgen Inc. rose $1.61 or 1.0 percent, to $157.66. Biogen Idec rose $1.32 or. 3 percent, to $408.05. Celgene Corp. rose $3.22 or 2.7 percent, to $123.43.

  • Midday Glance: Biotechnology companies Friday, 20 Feb 2015 | 1:36 PM ET

    Amgen Inc. rose$. 53 or. 3 percent, to $156.58. Biogen Idec fell$. 39 or. 1 percent, to $406.35. Celgene Corp. rose $2.89 or 2.4 percent, to $123.10.

  • Early Glance: Biotechnology companies Friday, 20 Feb 2015 | 10:50 AM ET

    Amgen Inc. rose$. 78 or. 5 percent, to $156.83. Biogen Idec fell $1.22 or. 3 percent, to $405.51. Celgene Corp. rose $2.39 or 2.0 percent, to $122.60.

  • Final Glance: Biotechnology companies Thursday, 19 Feb 2015 | 6:03 PM ET

    Amgen Inc. rose$. 27 or. 2 percent, to $156.05. Biogen Idec rose $5.61 or 1.4 percent, to $406.73. Celgene Corp. rose $1.80 or 1.5 percent, to $120.21.

  • Midday Glance: Biotechnology companies Thursday, 19 Feb 2015 | 1:28 PM ET

    Amgen Inc. fell$. 60 or. 4 percent, to $155.18. Biogen Idec rose $4.72 or 1.2 percent, to $405.84. Celgene Corp. rose $1.72 or 1.5 percent, to $120.13.

  • Early Glance: Biotechnology companies Thursday, 19 Feb 2015 | 10:50 AM ET

    Amgen Inc. fell$. 24 or. 2 percent, to $155.54. Biogen Idec rose $3.29 or. 8 percent, to $404.41. Celgene Corp. rose $1.55 or 1.3 percent, to $119.96.

  • Final Glance: Biotechnology companies Wednesday, 18 Feb 2015 | 6:30 PM ET

    Amgen Inc. rose $1.54 or 1.0 percent, to $155.78. Biogen Idec rose $3.21 or. 8 percent, to $401.12. Celgene Corp. rose $2.09 or 1.8 percent, to $118.41.

  • Midday Glance: Biotechnology companies Wednesday, 18 Feb 2015 | 1:18 PM ET

    Amgen Inc. rose$. 52 or. 3 percent, to $154.76. Biogen Idec rose$. 28 or. 1 percent, to $398.19. Celgene Corp. rose $1.29 or 1.1 percent, to $117.61.